CHEBI:229962 - LDN-212854

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name LDN-212854
ChEBI ID CHEBI:229962
Definition A member of the class of quinolines that is quinoline substituted by a 6-[4-(piperazin-1-yl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl group at position 5. It is a potent ALK inhibitor (IC50 values of 2.4, 1.3, 85.8, 2,133 and 9,276 nM for ALK1, ALK2, ALK3, ALK4 and ALK5, respectively).
Stars This entity has been manually annotated by the ChEBI Team.
Submitter Doug Howe
Supplier Information
Download Molfile XML SDF
Formula C25H22N6
Net Charge 0
Average Mass 406.493
Monoisotopic Mass 406.19059
InChI InChI=1S/C25H22N6/c1-3-21(22-4-2-10-27-24(22)5-1)23-16-29-31-17-19(15-28-25(23)31)18-6-8-20(9-7-18)30-13-11-26-12-14-30/h1-10,15-17,26H,11-14H2
InChIKey BBDGBGOVJPEFBT-UHFFFAOYSA-N
SMILES C1CN(CCN1)C1=CC=C(C=C1)C1=CN2N=CC(=C2N=C1)C1=C2C=CC=NC2=CC=C1
Roles Classification
Chemical Role(s): Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
Biological Role(s): EC 2.7.11.30 (receptor protein serine/threonine kinase) inhibitor
An EC 2.7.11.* (protein-serine/threonine kinase) inhibitor that interferes with the activity of receptor protein serine/threonine kinase (EC 2.7.11.30).
Application(s): antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
angiogenesis inhibitor
An agent and endogenous substances that antagonize or inhibit the development of new blood vessels.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing LDN-212854 (CHEBI:229962) has role angiogenesis inhibitor (CHEBI:48422)
LDN-212854 (CHEBI:229962) has role antineoplastic agent (CHEBI:35610)
LDN-212854 (CHEBI:229962) has role EC 2.7.11.30 (receptor protein serine/threonine kinase) inhibitor (CHEBI:137123)
LDN-212854 (CHEBI:229962) is a N-arylpiperazine (CHEBI:46848)
LDN-212854 (CHEBI:229962) is a pyrazolopyrimidine (CHEBI:38669)
LDN-212854 (CHEBI:229962) is a quinolines (CHEBI:26513)
IUPAC Name
5-{6-[4-(piperazin-1-yl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl}quinoline
Synonyms Sources
5-[6-[4-(1-piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]-quinoline ChEBI
LDN 212854 ChEBI
LDN212854 ChEBI
Citations Waiting for Citations Types Sources
23547776 PubMed citation Europe PMC
26626181 PubMed citation Europe PMC
27881824 PubMed citation Europe PMC
28427181 PubMed citation Europe PMC
28716575 PubMed citation Europe PMC
28918311 PubMed citation Europe PMC
30833574 PubMed citation Europe PMC
31619522 PubMed citation Europe PMC
33256557 PubMed citation Europe PMC
33834612 PubMed citation Europe PMC
35163396 PubMed citation Europe PMC
35563140 PubMed citation SUBMITTER
37174679 PubMed citation Europe PMC
38256056 PubMed citation Europe PMC
38581019 PubMed citation Europe PMC
PMC6477246 PubMed Central citation Europe PMC
Last Modified
12 April 2024